Cited time in webofscience Cited time in scopus

Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma

Title
Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma
Author(s)
Jang, Sung-IllCho, Jae-HeeKim, So-YoungHong, In-YoungPark, Jooon-SeongLee, Hye-SunPark, GoeunKim, Jong KyoungLee, Hyung-KeunLee, Dong-Ki
DGIST Authors
Jang, Sung-IllCho, Jae-HeeKim, So-YoungHong, In-YoungPark, Jooon-SeongLee, Hye-SunPark, GoeunKim, Jong KyoungLee, Hyung-KeunLee, Dong-Ki
Issued Date
2022-02
Type
Article
Author Keywords
interleukin-7 receptorcytokinediagnosispancreatic ductal adenocarcinoma
Keywords
INFLAMMATORY CYTOKINESCANCERINTERLEUKIN-7ASSOCIATIONINVOLVEMENTEXPRESSION
ISSN
2072-6694
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer for which no early diagnostic method is available. The immune surveillance hypothesis suggests that the immune system plays crucial roles in tumor development and progression. We validated a PDAC-specific bi-omarker derived from peripheral blood mononuclear cells (PBMCs) to facilitate early PDAC diag-nosis. mRNA levels of interleukin-7R (IL-7R), reportedly a potential immunological marker for PDAC, were measured in PBMCs isolated prospectively from healthy controls (n = 100) and patients with PDAC (n = 135), pancreatic cysts (n = 82), chronic pancreatitis (n = 42), acute pancreatitis (n = 47), and other malignancies (n = 116). The IL-7R level was significantly higher in patients with PDAC than in healthy controls, patients with benign pancreatic disease, and patients with other malignan-cies. As diagnostic parameters, the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for IL-7R were 58.5%, 92%, 90.8%, 62.2%, and 72.8%, respectively. The area under the receiver operating characteristic curve (AUROC) was 0.766. IL-7R levels did not dif-fer between resectable and unresectable PDAC cases. The combined measurement of IL-7R and car-bohydrate antigen 19-9 (CA19-9) significantly improved the diagnostic parameters and AUROC compared with the use of IL-7R or CA19-9 alone. IL-7R is significantly upregulated in PBMCs in patients with PDAC, and it may be a novel diagnostic marker for PDAC. The combined use of IL-7R and CA19-9 enhanced the diagnostic performance. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
URI
http://hdl.handle.net/20.500.11750/16939
DOI
10.3390/cancers14030853
Publisher
Multidisciplinary Digital Publishing Institute (MDPI)
Files in This Item:
2-s2.0-85124088285.pdf

2-s2.0-85124088285.pdf

기타 데이터 / 1.17 MB / Adobe PDF download
Appears in Collections:
Department of New Biology Laboratory of Single-Cell Genomics 1. Journal Articles

qrcode

  • twitter
  • facebook
  • mendeley

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE